Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retinal Biomarkers as a Tool for Early Detection of Endothelial Dysfunction in Women With Preeclampsia

NCT07084727 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT07084727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07084727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retinal Biomarkers as a Tool for Early Detection of Endothelial Dysfunction in Women With Preeclampsia
Lead sponsor
University Hospital, Antwerp
Phase
Not applicable
Overall status
Recruiting
Start date
July 1, 2025
Completion date
December 15, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endothelial function (fmd), preeclampsia, retinal vessels